Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Peringkat dalam Saham #12607
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Harga Saham
$9.09
Terakhir disinkronkan: 2023-06-23
Kapitalisasi Pasar
$567.77M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan CTI BioPharma Corp. (CTIC)

Kategori

Riwayat pemecahan saham untuk CTI BioPharma Corp. (CTIC)
Saham CTI BioPharma Corp. (simbol: CTIC) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 31, 2026.
Satu lembar saham CTIC yang dibeli sebelum Aug 31, 2026 sekarang setara dengan 0 lembar saham CTIC.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH